Henry L Gomez

13PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersMidwifery not elsewhere classifiedCancer geneticsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 04, 2026
"Carry-Over" Effect of CDK4/6 Inhibitors in Adjuvant Therapy for Hormone Receptor (HR)-Positive/HER2-Negative Early Breast Cancer: Clinical Evidence and Molecular Approach.

|Nov 24, 2025
Influence of HER2 Changes on Survival Outcomes After Neoadjuvant Chemotherapy in Peruvian Patients With Triple-Negative Breast Cancer.

Zaida Morante, Yomali Ferreyra, Iris Otoya

|Sep 29, 2025
Decision-Making Patterns for Clinically Node-Positive, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: Insights From a Survey of Breast Cancer Experts.

Yoonwon Kook, Minji Lee, Seung Ho Baek

|Sep 19, 2025
Clinical Management in BRCA Carriers with Early Breast Cancer.

Bruno Muñante, Roberto Paz-Manrique, Joseph A Pinto

|Jun 26, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Federico Rojo, Clive R Taylor, Carlos Barrios

|Jun 25, 2025
Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.

Jhony A De La Cruz-Vargas, Henry Gómez, Jesus E Talavera

Pageof 3

Frequent Collaborators

6 joint publications

Tatiana Vidaurre

5 joint publications

Carlos Castañeda

4 joint publications

Silvia P Neciosup

3 joint publications

Miluska Castillo